|
HNRNPUL2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.434000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.579000E-01 |
| Normal-vs-Stage2 |
6.798600E-01 |
| Normal-vs-Stage3 |
5.664000E-01 |
| Normal-vs-Stage4 |
6.559400E-01 |
| Stage1-vs-Stage2 |
8.002800E-01 |
| Stage1-vs-Stage3 |
3.256200E-01 |
| Stage1-vs-Stage4 |
8.144800E-01 |
| Stage2-vs-Stage3 |
3.765600E-01 |
| Stage2-vs-Stage4 |
9.550200E-01 |
| Stage3-vs-Stage4 |
3.542600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.674000E-01 |
| Normal-vs-AfricanAmerican |
1.311000E-01 |
| Normal-vs-Asian |
4.017400E-01 |
| Caucasian-vs-AfricanAmerican |
9.827800E-02 |
| Caucasian-vs-Asian |
3.923000E-01 |
| AfricanAmerican-vs-Asian |
4.169400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.256800E-01 |
| Normal-vs-Female |
6.396200E-01 |
| Male-vs-Female |
2.606000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.418000E-01 |
| Normal-vs-Age(41-60Yrs) |
5.796400E-01 |
| Normal-vs-Age(61-80Yrs) |
4.594200E-01 |
| Normal-vs-Age(81-100Yrs) |
3.802200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.107000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.631200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.217600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.674410E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.626600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.810200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.127380E-01 |
| Classical-VS-Follicular |
3.66910000160203E-08 |
| Classical-VS-Other |
1.222200E-01 |
| Classical-VS-Normal |
7.303900E-02 |
| Tall-VS-Follicular |
4.472400E-02 |
| Tall-VS-Other |
4.652000E-01 |
| Tall-VS-Normal |
7.150800E-01 |
| Follicular-VS-Other |
7.917200E-01 |
| Follicular-VS-Normal |
6.423100E-03 |
| Other-VS-Normal |
4.949600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.968000E-01 |
| Normal-vs-N1 |
2.445800E-01 |
| N0-vs-N1 |
4.175600E-01 |
|
|
